• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用瞳孔测量法评估帕金森病中的自主神经受累情况。

Evaluation of autonomic involvement in Parkinson's disease using pupillometry.

作者信息

İşcan Dilek, Türkoğlu Ceren, Arslan Elif

机构信息

Faculty of Medicine, Department of Neurology, Niğde Ömer Halisdemir University, Niğde, 51240, Turkey.

Faculty of Medicine, Department of Ophthalmology, Lokman Hekim University, Ankara, Turkey.

出版信息

Neurol Sci. 2025 Apr 15. doi: 10.1007/s10072-025-08182-y.

DOI:10.1007/s10072-025-08182-y
PMID:40232633
Abstract

INTRODUCTION

The pupillary light reflex (PLR) indicates the function of the autonomic nervous system, which causes the pupil to constrict and dilate. Evaluation of the PLR determines the parasympathetic and sympathetic balance. We aimed to demonstrate autonomic changes by pupillometry in Parkinson'd disease (PD) and to investigate the relationship between the changes and motor stage and levodopa equivalent dose (LEDD).

METHOD

Static pupillometry measurement was performed at scotopic, mesopic and photopic settings. Dynamic pupillometry measurement was performed at 500 lux illumination and pupil diameter was recorded. Static and dynamic pupillometry parameters of Parkinson's disease patients and healthy control group of similar age and gender were compared. The relationship between Unified Parkinson's Disease Rating Scale (UPDRS)-motor, modified Hoehn and Yahr (mHYE) and levodopa equivalent daily dose (LEDD) and pupillometry parameters were analysed.

RESULTS

In static pupillometry, mesopic pupil diameter was significantly lower in PD patients (P = 0.04). In dynamic pupillometry, pupil diameter was lower and mean pupil dilation rate was lower in the PD group at 18 seconds. There was a significant negative correlation between mean pupil dilatation velocity and mHYE, UPDRS-motor and LEDD. The mean pupil dilatation velocity was statistically significantly lower in patients not receiving dopaminergic treatment.

CONCLUSION

Changes in pupillometry values in PD have emphasized that the autonomic nervous system is affected and the parasympathetic nervous system was found to be correlated with the motor involvement of the disease.

摘要

引言

瞳孔对光反射(PLR)表明自主神经系统的功能,该系统会导致瞳孔收缩和扩张。对PLR的评估可确定副交感神经和交感神经的平衡。我们旨在通过瞳孔测量法证明帕金森病(PD)患者的自主神经变化,并研究这些变化与运动阶段和左旋多巴等效剂量(LEDD)之间的关系。

方法

在暗视、中间视觉和明视条件下进行静态瞳孔测量。在500勒克斯光照下进行动态瞳孔测量,并记录瞳孔直径。比较帕金森病患者和年龄、性别相似的健康对照组的静态和动态瞳孔测量参数。分析统一帕金森病评定量表(UPDRS)-运动部分、改良Hoehn和Yahr分级(mHYE)以及左旋多巴等效日剂量(LEDD)与瞳孔测量参数之间的关系。

结果

在静态瞳孔测量中,PD患者的中间视觉瞳孔直径显著较低(P = 0.04)。在动态瞳孔测量中,PD组在18秒时的瞳孔直径较小,平均瞳孔扩张率较低。平均瞳孔扩张速度与mHYE、UPDRS-运动部分和LEDD之间存在显著负相关。未接受多巴胺能治疗的患者平均瞳孔扩张速度在统计学上显著较低。

结论

PD患者瞳孔测量值的变化强调了自主神经系统受到影响,并且发现副交感神经系统与疾病的运动受累相关。

相似文献

1
Evaluation of autonomic involvement in Parkinson's disease using pupillometry.使用瞳孔测量法评估帕金森病中的自主神经受累情况。
Neurol Sci. 2025 Apr 15. doi: 10.1007/s10072-025-08182-y.
2
Quantitative automated pupillometry in diabetic patients and correlation with retinal nerve fibre layer thickness.糖尿病患者的定量自动瞳孔测量及其与视网膜神经纤维层厚度的相关性。
Eye (Lond). 2025 Apr 10. doi: 10.1038/s41433-025-03793-3.
3
The Long-Term Impact of Levodopa/Carbidopa Intestinal Gel on 'Off'-time in Patients with Advanced Parkinson's Disease: A Systematic Review.左旋多巴/卡比多巴肠凝胶对晚期帕金森病患者“关”期的长期影响:一项系统评价
Adv Ther. 2021 Jun;38(6):2854-2890. doi: 10.1007/s12325-021-01747-1. Epub 2021 May 20.
4
Safety and tolerability of intravenous liposomal GM1 in patients with Parkinson disease: A single-center open-label clinical phase I trial (NEON trial).静脉注射脂质体GM1治疗帕金森病患者的安全性和耐受性:一项单中心开放标签的I期临床试验(NEON试验)。
PLoS Med. 2025 May 13;22(5):e1004472. doi: 10.1371/journal.pmed.1004472. eCollection 2025 May.
5
Pupillographic evaluation accompanying structural and functional assessment of the optic nerve in patients with Parkinson's disease.帕金森病患者视神经结构和功能评估中的瞳孔测量评估
BMC Ophthalmol. 2025 Jul 8;25(1):397. doi: 10.1186/s12886-025-04219-0.
6
Bromocriptine versus levodopa in early Parkinson's disease.早期帕金森病中溴隐亭与左旋多巴的对比
Cochrane Database Syst Rev. 2000(3):CD002258. doi: 10.1002/14651858.CD002258.
7
Investigation of anterior segment and pupillometry changes with Sirius corneal topography in chronic smokers.慢性吸烟者前节及瞳孔测量随Sirius角膜地形图的变化研究
BMC Ophthalmol. 2025 Jul 1;25(1):381. doi: 10.1186/s12886-025-04131-7.
8
Evaluation of the efficacy and safety of adjuvant treatment to levodopa therapy in Parkinson s disease patients with motor complications.帕金森病运动并发症患者左旋多巴治疗辅助治疗的疗效与安全性评估。
Cochrane Database Syst Rev. 2010 Jul 7(7):CD007166. doi: 10.1002/14651858.CD007166.pub2.
9
Effects of levodopa/carbidopa intestinal gel infusion on autonomic symptoms in advanced Parkinson's disease: a systematic review.左旋多巴/卡比多巴肠凝胶输注对晚期帕金森病自主神经症状的影响:一项系统评价
Clin Auton Res. 2025 Apr;35(2):159-182. doi: 10.1007/s10286-024-01090-9. Epub 2024 Dec 4.
10
Monoamine oxidase B inhibitors for early Parkinson's disease.用于早期帕金森病的单胺氧化酶B抑制剂
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD004898. doi: 10.1002/14651858.CD004898.pub2.

引用本文的文献

1
Longitudinal analysis of pupillometry according to type of pharmacotherapy in Parkinson's disease patients.帕金森病患者药物治疗类型的瞳孔测量纵向分析
Sci Rep. 2025 Aug 20;15(1):30525. doi: 10.1038/s41598-025-15306-z.
2
Pupillographic evaluation accompanying structural and functional assessment of the optic nerve in patients with Parkinson's disease.帕金森病患者视神经结构和功能评估中的瞳孔测量评估
BMC Ophthalmol. 2025 Jul 8;25(1):397. doi: 10.1186/s12886-025-04219-0.

本文引用的文献

1
Pupil light reflex dynamics in Parkinson's disease.帕金森病中的瞳孔光反射动力学
Front Integr Neurosci. 2023 Aug 31;17:1249554. doi: 10.3389/fnint.2023.1249554. eCollection 2023.
2
Visual Dysfunction in Parkinson's Disease.帕金森病中的视觉功能障碍
Brain Sci. 2023 Aug 7;13(8):1173. doi: 10.3390/brainsci13081173.
3
Analysis of pupillometer results according to disease stage in patients with Parkinson's disease.根据帕金森病患者的疾病阶段分析瞳孔计结果。
Sci Rep. 2021 Sep 9;11(1):17880. doi: 10.1038/s41598-021-97599-4.
4
Variable abnormality of the melanopsin-derived portion of the pupillary light reflex (PLR) in patients with Parkinson's disease (PD) and parkinsonism features.帕金森病(PD)及帕金森综合征患者瞳孔对光反射(PLR)中源自黑视蛋白部分的可变异常。
Neurol Sci. 2022 Jan;43(1):349-356. doi: 10.1007/s10072-021-05245-8. Epub 2021 May 4.
5
Melanopsin Cell Dysfunction is Involved in Sleep Disruption in Parkinson's Disease.黑视素细胞功能障碍与帕金森病睡眠障碍有关。
J Parkinsons Dis. 2020;10(4):1467-1476. doi: 10.3233/JPD-202178.
6
Levodopa Equivalent Dose Conversion Factors: An Updated Proposal Including Opicapone and Safinamide.左旋多巴等效剂量转换因子:一项包括奥匹卡朋和沙芬酰胺的更新提案。
Mov Disord Clin Pract. 2020 Mar 16;7(3):343-345. doi: 10.1002/mdc3.12921. eCollection 2020 Apr.
7
Autonomic dysfunction in Parkinson's disease: Implications for pathophysiology, diagnosis, and treatment.帕金森病的自主神经功能障碍:对病理生理学、诊断和治疗的影响。
Neurobiol Dis. 2020 Feb;134:104700. doi: 10.1016/j.nbd.2019.104700. Epub 2019 Dec 3.
8
Understanding the effects of mild traumatic brain injury on the pupillary light reflex.了解轻度创伤性脑损伤对瞳孔光反射的影响。
Concussion. 2017 Aug 3;2(3):CNC36. doi: 10.2217/cnc-2016-0029. eCollection 2017 Nov.
9
Pupillometry as an indicator of L-DOPA dosages in Parkinson's disease patients.瞳孔测量术作为帕金森病患者 L-DOPA 剂量的指标。
J Neural Transm (Vienna). 2018 Apr;125(4):699-703. doi: 10.1007/s00702-017-1829-1. Epub 2017 Dec 19.
10
Ocular and visual disorders in Parkinson's disease: Common but frequently overlooked.帕金森病中的眼部和视觉障碍:常见但常被忽视。
Parkinsonism Relat Disord. 2017 Jul;40:1-10. doi: 10.1016/j.parkreldis.2017.02.014. Epub 2017 Feb 21.